APLI — Appili Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$4.85m
- CA$12.26m
- CA$0.33m
Annual balance sheet for Appili Therapeutics, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.45 | 10.5 | 16.1 | 6.66 | 2.47 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.917 | 0.313 | 1.69 | 1.39 | 0.421 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 6.76 | 11.1 | 18.3 | 8.24 | 3.12 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.08 | 0.063 | 0.055 | 0.042 | 0.015 |
| Total Assets | 6.84 | 11.2 | 18.3 | 8.28 | 3.13 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.35 | 1.38 | 4.62 | 6.67 | 2.98 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.42 | 2.33 | 5.56 | 11.6 | 10.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.42 | 8.85 | 12.8 | -3.27 | -7.4 |
| Total Liabilities & Shareholders' Equity | 6.84 | 11.2 | 18.3 | 8.28 | 3.13 |
| Total Common Shares Outstanding |